Pharma's TV blitz, biotech's IPO trickle, and the M&A future of Intercept Pharmaceuticals
Released: Feb 18, 2016
Fierce editors discuss the rise of TV ads for specialty drugs, signs of life in the biotech IPO scene, and the case for Intercept Pharmaceuticals as a buyout target.
